Peihua Lu

机构：Sinopec (China), Fifth Affiliated Hospital of Zhengzhou University, Luye Pharma (China), First Affiliated Hospital of Zhengzhou University, Wuxi People's Hospital, Langfang Normal University, Nanjing Medical University · ORCID：0009-0005-2855-8780

发表论文 64 篇 · 总被引 499 次 · h-index 6

代表论文

• Dynamic Tumor Immunology-on-a-Chip for Peripheral Blood-Derived Tumor-Reactive T Cell Expansion (2025 · Research · 被引 12)
• Peripheral blood CD8 + CD28+ T cells as predictive biomarkers for treatment response in metastatic colorectal cancer (2025 · Biomarkers · 被引 5)
• CD7-Targeted CAR-T Cell Therapy Shows Promising Efficacy and Safety in Treating Refractory/Relapsed Peripheral T-Cell Lymphoma: Phase I Clinical Trial (2024 · Blood · 被引 4)
• Neo-BCV: A Novel Bacterial Liquid Complex Vaccine for Enhancing Dendritic Cell-Mediated Immune Responses Against Lung Cancer (2025 · Vaccines · 被引 2)
• Correction: Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group (2024 · Bone Marrow Transplantation · 被引 2)
• A Novel Full-Spectral Flow Cytometric Assay for Detection of Measurable Residual Disease in Patients with B-Lymphoblastic Leukemia (2024 · Blood · 被引 2)